与Helicobacter pylori相关的胃癌发生的景观
Paulo Pimentel de Assumpção1, Robert M Genta2, Maria Constanza Camargo3
1Núcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Pará, Brazil. assumpcaopp@gmail.com.
Journal of gastrointestinal and liver diseases : JGLD
|December 29, 2024
概括
杆菌 (H. pylori) 是胃癌 (GC) 发展的核心因素,通常与其他因素合作. 这项研究完善了H. pylori胃癌发生模型,以改善GC的早期检测和干预策略.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 微生物学 微生物学
背景情况:
- 杆菌 (H. pylori) 感染是胃癌 (GC) 的主要驱动因素,尽管其确切的机制和与其他因素的相互作用是复杂的.
- 识别高风险个体和早期GC仍然是一个重大的临床挑战.
- 胃癌发生现有的模型并不能完全捕捉到H. pylori的多方面的作用.
研究的目的:
- 通过整合分子数据,一般瘤学原理和新型实验发现,完善现有的胃致癌模型.
- 为了更全面地了解H. pylori在肠道和扩散GC中的作用.
- 加强对H. pylori相关的GC高风险个体的鉴定,并促进早期疾病检测.
主要方法:
- 将分子数据纳入已建立的Pelayo Correa致癌途径.
- 整合常见的瘤学概念和来自创新实验方法的数据.
- 扩展模型,包括H. pylori与干细胞和其他未被认可的致癌机制的相互作用.
主要成果:
- 这种精细的模型提供了对H. pylori对GC发展的贡献的更全面的观点.
- 它强调了H. pylori毒性因子和间接机制的直接细胞效应.
- 更新后的模型承认了额外的分子驱动因素以及H. pylori在这些过程中的潜在参与.
结论:
- 增强的胃癌发生模型提供了更精确的解释GC发展.
- 它强调了H. pylori的关键作用,以及其他分子驱动因素.
- 这种改进的模型可能为有针对性的临床干预和改善患者结果开辟新的途径.
相关概念视频
01:17Gastritis-II: Pathophysiology
155
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
155
01:30Peptic Ulcer Disease I: Introduction
81
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
81
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
474
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
474
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
305
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
305
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
62
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
62
01:28Peptic Ulcer Disease II: Pathophysiology
133
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
133